Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

48 recalls · Class III, newest first

Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-912-01 D-1423-2015
Class III · Low risk

Glenmark Topiramate Tablets

Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-110-60 D-331-2013
Class III · Low risk

Glenmark Pravastatin Sodium Tablets

Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to an off-odor described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-197-90 D-330-2013
Class III · Low risk

Glenmark Gabapentin Tablets

Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off - odor described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-126-05 D-329-2013
Class III · Low risk

Camila 0.35 mg Tablets

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Terminated Chemical / undeclared Physicians Total Care, Inc. NDC 54868-4814-0 D-499-2013
Class III · Low risk

Camila (norethindrone tablets, USP)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Terminated Chemical / undeclared Teva Pharmaceuticals USA, Inc. NDC 0555-0715-58 D-690-2013
Class III · Low risk

Errin (norethindrone tablets, USP)

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Terminated Chemical / undeclared Teva Pharmaceuticals USA, Inc. NDC 0555-0344-58 D-689-2013
Class III · Low risk

Junel

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Terminated Chemical / undeclared Teva Pharmaceuticals USA, Inc. NDC 0555-9028-58 D-682-2013
Class III · Low risk

Jevantique

Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

Terminated Chemical / undeclared Warner Chilcott Company LLC NDC 52544-237-19 D-304-2013
Class III · Low risk

Montelukast Sodium Tablets

Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-392-30 D-182-2013
Class III · Low risk

Erythromycin Topical Solution USP

Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.

Terminated Chemical / undeclared Fougera Pharmaceuticals, Inc. NDC 0168-0215-60 D-1426-2012
Class III · Low risk

Earth Force

Chemical Contamination: QS Plus wipes were found to be contaminated with different substance (7820, Graffiti Remover).

Terminated Chemical / undeclared Abc Compounding Company Inc D-011-2013
Class III · Low risk

Plavix 75 mg

Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).

Terminated Chemical / undeclared Physicians Total Care, Inc. D-317-2013

Recalls by year